home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
Shareware Overload Trio 2
/
Shareware Overload Trio Volume 2 (Chestnut CD-ROM).ISO
/
dir26
/
med9410m.zip
/
M94A2123.TXT
< prev
next >
Wrap
Text File
|
1994-10-25
|
3KB
|
42 lines
Document 2123
DOCN M94A2123
TI HIV/AIDS in Sweden. Health and medical care estimates with respect to
CD4 levels and survival.
DT 9412
AU Malmquist H; Nilsson BR; National Swedish Board of Health and Welfare,
Stockholm.
SO Int Conf AIDS. 1994 Aug 7-12;10(1):376 (abstract no. PD0110). Unique
Identifier : AIDSLINE ICA10/94370452
AB OBJECT. The aim for this study was to give estimates on somatic care for
HIV infected patients in Sweden. METHOD. Survival data on HIV positive
patients (n = 2,253) was gathered from Danderyd and Huddinge university
hospitals. Stockholm, stratified on CD4 values < = 200, 201-300 and
301-500 units. Survival times for patients within these strata were
calculated by the life table method. Median survival times were then
used to calculate mean expected costs for the patients within the
different CD4-group. Knowing the distribution of patients on stage and
costs per patient on stage we were able to give cost estimates for
somatic care for the Swedish HIV population with CD4-count below 500
units for the rest of the life for the patients. RESULTS. The mean
expected survival time for a HIV patient with a CD4 value below 500
units was estimated to be 4.7 years. The distribution of HIV infected
persons was assumed to be the same for the total known Swedish HIV
population as for the Danderyd/Huddinge cohort. Of 2,519 known HIV
infected persons in Sweden (Jan 1993) 1,887 (75%) could be estimated to
have CD4-counts below 500 units. The expected number of person years
(py) until death for these patients would than be 4.7 years x 1,887
patients = 8,878 py. The total costs for this population is estimated to
be 1.2 billion SEK, i.e. 154 million USD. CONCLUSION. By combinating the
number of HIV patients by CD4 level and costs per py as estimated by
median survival times it was possible to calculate estimates on costs
for medical care for cohorts of patients in Sweden.
DE Acquired Immunodeficiency Syndrome/*ECONOMICS/IMMUNOLOGY/ MORTALITY
Cohort Studies Comprehensive Health Care/*ECONOMICS Costs and Cost
Analysis Human HIV Infections/*ECONOMICS/IMMUNOLOGY/MORTALITY
Leukocyte Count Life Expectancy Survival Rate Sweden T4
Lymphocytes/IMMUNOLOGY MEETING ABSTRACT
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).